HomeTagsCAR-T Cell Therapy

CAR-T Cell Therapy

Biotechnology

Body of Evidence Grows From ZUMA-7 Study Supporting Initial Treatment

Business Wire - December 12, 2022

Kite, a Gilead Company announced findings from two new analyses of the landmark ZUMA-7 trial of Yescarta, the largest and longest follow-up of a...

Biotechnology

Regen BioPharma, Inc. Begins Experiments Validating Its Proprietary CAR-T Cell Therapy

PR Newswire - September 14, 2022

Regen BioPharma, Inc. announced initiation of a series of phased experiments to begin the process of moving its CAR-T cell de-differentiation approach through pre-clinical...

Biotechnology

IASO Bio’s Nanjing Manufacturing Facility Granted the Drug Manufacturing License for CAR-T Cell Therapy Products

PR Newswire - March 2, 2022

IASO Biotherapeutics, a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products announced that the company's commercial manufacturing...

Hot Topics

Manhattan Pioneers Use of GenAI in Supply Chain Commerce

Crisp Acquires Both Lumidata and SetSight to Unify Retail Data, Enabling CPG Brand Growth with Target

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial

Manhattan Pioneers Use of GenAI in Supply Chain Commerce

Crisp Acquires Both Lumidata and SetSight to Unify Retail Data, Enabling…

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep…

Porotech Selects ClassOne Solstice® Single-Wafer Platform for Development and Manufacture of…

CAR-T Cell Therapy

Hot Topics

Manhattan Pioneers Use of GenAI in Supply Chain Commerce

Crisp Acquires Both Lumidata and SetSight to Unify Retail Data, Enabling CPG Brand Growth with Target

Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial